Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Kathryn G Roberts
Affiliation
St Jude Children's Research Hospital
ORCID
Career Start Year
2006
Papers
87
H Index
41
Expertise
CM4AI Collaborator
Andrej Sali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37890117
Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group.
J Clin Oncol
2024
36658389
Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia.
Leukemia
2023
37986997
Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very young.
medRxiv
2023
37729596
Prognostic and Pharmacotypic Heterogeneity of Hyperdiploidy in Childhood ALL.
J Clin Oncol
2023
37216686
The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
Blood
2023
37196217
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in <i>ABL</i> Class Rearrangements.
JCO Precis Oncol
2023
36877196
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia.
Am J Hematol
2023
36604538
Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response.
Nat Med
2023
35192684
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.
Blood
2022
35442720
Acute Leukemia Classification Using Transcriptional Profiles From Low-Cost Nanopore mRNA Sequencing.
JCO Precis Oncol
2022
35671062
Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia.
Blood Adv
2022
35590059
Acute lymphoblastic leukemia displays a distinct highly methylated genome.
Nat Cancer
2022
36518527
A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1.
NAR Cancer
2022
36138187
NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia.
Nat Immunol
2022
36050548
The genomic landscape of pediatric acute lymphoblastic leukemia.
Nat Genet
2022
35247902
ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute Leukemia.
Blood Cancer Discov
2022
35115686
Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation.
Nat Genet
2022
35084434
Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia.
JAMA Oncol
2022
35323882
CDX2 and IDH1/2: new potential players in ALL.
Blood
2022
32881995
Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL.
Blood
2021
33626861
The <i>EBF1-PDGFRB</i> T681I mutation is highly resistant to imatinib and dasatinib <i>in vitro</i> and detectable in clinical samples prior to treatment.
Haematologica
2021
33593877
Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
Cancer Discov
2021
33707599
Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan.
Sci Rep
2021
33895809
Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.
Blood
2021
34907175
Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia.
Nat Commun
2021
34424946
The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13.
Blood
2021
34250504
Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.
Blood Cancer Discov
2021
34103329
Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell Leukemia.
Cancer Discov
2021
34151288
Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia.
Nat Cancer
2021
34062932
Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia.
Genes (Basel)
2021
34110416
Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia.
Blood
2021
33288732
The Heme-Regulated Inhibitor Pathway Modulates Susceptibility of Poor Prognosis B-Lineage Acute Leukemia to BH3-Mimetics.
Mol Cancer Res
2021
33197935
SSBP2-CSF1R is a recurrent fusion in B-lineage acute lymphoblastic leukemia with diverse genetic presentation and variable outcome.
Blood
2021
33275800
GATA3 rs3824662A allele in B-cell acute lymphoblastic leukemia in adults, adolescents and young adults: association with CRLF2 rearrangement and poor prognosis.
Am J Hematol
2021
33357483
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study.
Lancet Haematol
2021
32220069
At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial.
Br J Haematol
2020
31653664
The Biology of B-Progenitor Acute Lymphoblastic Leukemia.
Cold Spring Harb Perspect Med
2020
33164984
Pharmacogenomics of intracellular methotrexate polyglutamates in patients' leukemia cells in vivo.
J Clin Invest
2020
32793890
Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia.
Blood Cancer Discov
2020
32589978
Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial.
Lancet Haematol
2020
32470390
Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia.
Cancer Cell
2020
30643249
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.
Nat Genet
2019
31015346
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL.
Clin Cancer Res
2019
30510082
Novel susceptibility variants at the <i>ERG</i> locus for childhood acute lymphoblastic leukemia in Hispanics.
Blood
2019
29487712
Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in <i>CRLF2</i> rearranged and/or <i>JAK</i> driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia.
Oncotarget
2018
29997224
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.
Blood
2018
29880614
ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition.
Blood
2018
30504302
Genetics and prognosis of ALL in children vs adults.
Hematology Am Soc Hematol Educ Program
2018
30466746
Why and how to treat Ph-like ALL?
Best Pract Res Clin Haematol
2018
29773543
TKI resistance in Ph-like ALL.
Blood
2018
1 - 50 of 87
Column Actions
Search
Recommended Authors
Samantha L Savage
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
2016
Number of shared co-authors
7
Ann-Kathrin Eisfeld
The Ohio State University Comprehensive Cancer Center
Career Start Year
2011
Number of shared co-authors
8
Kara L Davis
Stanford University School of Medicine
Career Start Year
2008
Number of shared co-authors
10
Jennifer Dunlap
Oregon Health & Science University
Career Start Year
2008
Number of shared co-authors
6
Amanda Winters
University of Colorado School of Medicine
Career Start Year
2008
Number of shared co-authors
0
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year
2007
Number of shared co-authors
6
Pascal St-Onge
CHU Sainte-Justine Research Center
Career Start Year
2007
Number of shared co-authors
2
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
2006
Number of shared co-authors
8
Don??t Alp??r
Semmelweis University
Career Start Year
2006
Number of shared co-authors
0
Emmanuelle Clappier
Saint-Louis Hospital
Career Start Year
2005
Number of shared co-authors
6
Yana Pikman
Dana Farber Cancer Institute
Career Start Year
2005
Number of shared co-authors
9
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year
2005
Number of shared co-authors
10
Patrick Brown
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Career Start Year
2004
Number of shared co-authors
19
Rhonda E Ries
Clinical Research Division, Fred Hutchinson Cancer Research Center
Career Start Year
2003
Number of shared co-authors
43
Christopher C Porter
Emory University School of Medicine
Career Start Year
2003
Number of shared co-authors
8
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Career Start Year
2002
Number of shared co-authors
21
Thomas Ernst
Universitatsklinikum Jena
Career Start Year
2002
Number of shared co-authors
5
Guang Fan
Oregon Health and Science University
Career Start Year
2000
Number of shared co-authors
4
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year
1998
Number of shared co-authors
16
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year
1996
Number of shared co-authors
7
Brian J P Huntly
University of Cambridge
Career Start Year
1996
Number of shared co-authors
10
Mar??a D Odero
University of Navarra
Career Start Year
1994
Number of shared co-authors
0
Bill H Chang
Oregon Health and Science University
Career Start Year
1993
Number of shared co-authors
8
Seishi Ogawa
Kyoto University
Career Start Year
1993
Number of shared co-authors
16
Michael Heuser
Hannover Medical School
Career Start Year
1993
Number of shared co-authors
20
Derek L Stirewalt
Fred Hutchinson Cancer Center
Career Start Year
1992
Number of shared co-authors
12
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year
1992
Number of shared co-authors
12
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
1991
Number of shared co-authors
8
Daniel J DeAngelo
Dana-Farber Cancer Institute
Career Start Year
1989
Number of shared co-authors
19
Soheil Meshinchi
Fred Hutchinson Cancer Research Centre
Career Start Year
1987
Number of shared co-authors
50
row(s) 1 - 30 of 30
Collaborators
Charles G Mullighan
St Jude Children's Research Hospital
Co-authored papers
77
Stephen P Hunger
Children's Hospital of Philadelphia
Co-authored papers
27
Mignon L Loh
University of Washington
Co-authored papers
26
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Co-authored papers
21
Ching-Hon Pui
St. Jude Children's Research Hospital
Co-authored papers
21
Mary V Relling
Departments of Pharmaceutical Sciences.
Co-authored papers
18
Meenakshi Devidas
St Jude Children's Research Hospital
Co-authored papers
18
William E Evans
Departments of Oncology. St. Jude Children's Research Hospital
Co-authored papers
16
Chunxu Qu
Co-authored papers
16
Cheng Cheng
St. Jude Children's Research Hospital
Co-authored papers
15
Sima Jeha
St. Jude Children's Research Hospital
Co-authored papers
14
Julie M Gastier-Foster
Baylor College of Medicine
Co-authored papers
12
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Co-authored papers
11
Stanley Pounds
St. Jude Children's Research Hospital.
Co-authored papers
10
Michael Rusch
St Jude Children's Research Hospital
Co-authored papers
10
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Co-authored papers
9
John Easton
St Jude Children's Research Hospital
Co-authored papers
9
Kristine R Crews
St. Jude Children's Research Hospital
Co-authored papers
8
Anthony V Moorman
Translational and Clinical Research Institute, Newcastle University
Co-authored papers
8
Yongjin Li
Mayo Clinic
Co-authored papers
8
Martin S Tallman
Memorial Sloan-Kettering Cancer Center
Co-authored papers
7
Xiang Chen
St. Jude Children's Research Hospital
Co-authored papers
7
John E Dick
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
6
Krzysztof Mr??zek
The Ohio State Comprehensive Cancer Center
Co-authored papers
6
Malcolm A Smith
National Cancer Institute
Co-authored papers
6
Yunfeng Dai
Colleges of Medicine, University of Florida
Co-authored papers
6
Daniela S Gerhard
National Cancer Institute
Co-authored papers
5
Xiaotu Ma
St. Jude Children's Research Hospital
Co-authored papers
5
Michael N Edmonson
St. Jude Children's Research Hospital
Co-authored papers
5
Ravi Bhatia
University of Alabama at Birmingham
Co-authored papers
4
1 - 30